Literature DB >> 31742641

Association between depression and rheumatoid arthritis: two longitudinal follow-up studies using a national sample cohort.

So Young Kim1, Min Chanyang2,3, Dong Jun Oh4, Hyo Geun Choi2,5.   

Abstract

OBJECTIVE: To investigate the bidirectional relation between RA and depression.
METHODS: Data from the Korean Health Insurance Review and Assessment Service - National Sample Cohort from 2002 to 2013 were analysed. Patients ≥20 years of age were included. Study I was conducted with 38 087 depression patients and 152 348 matched control participants. Study II was conducted with 7385 RA patients and 29 540 matched control participants. Stratified Cox proportional hazards models were used to analyse the hazard ratios (HRs) for depression and RA (study I) and for RA and depression (study II). The data were adjusted by the Charlson comorbidity index; rheumatic disease was excluded. Subgroups were also analysed according to age and sex.
RESULTS: A total of 0.7% (1260/38 087) of the depression group and 0.6% (883/152 348) of the control I group had RA (P = 0.02). The HR for RA in the depression group was not significantly higher than that in control I group. In study II, 5.5% (408/7385) of the RA group and 4.3% (1246/29 540) of the control II group presented with depression (P < 0.001). The RA patients showed an adjusted depression HR that was 1.20 times higher (95% CI 1.07, 1.34; P = 0.002) than that of the control group. The >30-years-old and women subgroups of RA patients showed higher depression HRs than the control subgroups.
CONCLUSION: RA increased the risk of depression; however, depression did not increase the risk of RA in the Korean adult population.
© The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  arthritis; cohort studies; depression; epidemiology; rheumatoid; risk factors

Mesh:

Year:  2020        PMID: 31742641     DOI: 10.1093/rheumatology/kez559

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  7 in total

1.  Population-based study for the comorbidities and associated factors in Ménière's disease.

Authors:  Min Hee Kim
Journal:  Sci Rep       Date:  2022-05-18       Impact factor: 4.996

Review 2.  Beyond Rheumatoid Arthritis Evaluation: What are We Missing?

Authors:  Gianna Espinoza; Genessis Maldonado; Jemina Narvaez; Roberto Guerrero; Gustavo Citera; Carlos Rios
Journal:  Open Access Rheumatol       Date:  2021-03-25

3.  Suicide Risk in Rheumatoid Arthritis Patients is Associated With Suboptimal Vitamin D Levels.

Authors:  Ivette Calderón Espinoza; Efrain Chavarria-Avila; Oscar Pizano-Martinez; Erika Aurora Martínez-García; Juan Armendariz-Borunda; Ana Laura Marquez-Aguirre; Arcelia Llamas-García; Esther Guadalupe Corona-Sánchez; Guillermo Toriz González; Monica Vazquez-Del Mercado
Journal:  J Clin Rheumatol       Date:  2022-04-01       Impact factor: 3.517

4.  No travel worsens depression: reciprocal relationship between travel and depression among older adults.

Authors:  Seungjae Hyun; Yeonjin Lee; Sangshin Park
Journal:  Ann Gen Psychiatry       Date:  2022-08-10       Impact factor: 3.301

Review 5.  Non-pharmacological treatment in difficult-to-treat rheumatoid arthritis.

Authors:  Judit Majnik; Noémi Császár-Nagy; Georgina Böcskei; Tamás Bender; György Nagy
Journal:  Front Med (Lausanne)       Date:  2022-08-29

6.  Depression and Subsequent Risk for Incident Rheumatoid Arthritis Among Women.

Authors:  Jeffrey A Sparks; Susan Malspeis; Jill Hahn; Jiaqi Wang; Andrea L Roberts; Laura D Kubzansky; Karen H Costenbader
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-01       Impact factor: 4.794

7.  Self-care recommendations for patients with rheumatic diseases during the COVID-19 pandemic.

Authors:  Hyun-Sook Kim; Myeung-Su Lee; HyungJin Kim; Yoon-Kyoung Sung; Jisoo Lee; Seung-Cheol Shim; Sung-Hwan Park; Han Joo Baek
Journal:  Rheumatol Int       Date:  2020-06-02       Impact factor: 2.631

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.